Systemic lupus erythematosus-like disease in a 6-year-old boy with prolidase deficiency

M Di Rocco1, A R Fantasia, M Taro

  • 12nd Division of Pediatrics, University of Genoa, G. Gaslini Institute, Largo Gaslini 5, 16147, Genoa, Italy. majadirocco@ospedale-gaslini.ge.it

Insights

Prolidase deficiency can mimic systemic lupus erythematosus, presenting with similar immunological features and skin lesions. Early diagnosis of this metabolic disorder is crucial for appropriate management.

Area of Science:

  • Immunology
  • Metabolic Disorders
  • Dermatology

Background:

  • Prolidase deficiency is a rare inherited metabolic disorder.
  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
  • Both conditions can present with complex immunological and clinical manifestations.

Observation:

  • A pediatric case presented with splenomegaly, leg ulcers, and significant immunological abnormalities including hypergammaglobulinaemia and autoantibodies.
  • Initial diagnosis of SLE was considered due to vasculitic skin lesions and positive autoantibodies, but diagnostic criteria were not fully met.
  • Immunosuppressive therapy for suspected SLE worsened the skin lesions.

Findings:

  • The patient was ultimately diagnosed with prolidase deficiency, a metabolic disorder.
  • Prolidase deficiency shares immunological similarities with SLE, including autoantibody production and complement consumption.
  • The metabolic defect in prolidase deficiency may contribute to immune dysregulation through altered apoptosis processing.

Implications:

  • This case highlights the importance of considering metabolic disorders in the differential diagnosis of autoimmune diseases.
  • Understanding the link between prolidase deficiency and immune dysfunction may reveal new pathogenetic pathways for autoimmune conditions.
  • Further research into the role of apoptosis and immune clearance mechanisms in prolidase deficiency is warranted.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pedigree Analysis01:35

Pedigree Analysis

Overview
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...